Pharmac has today confirmed the access criteria for the first preventative medicine for COVID-19, tixagevimab and cilgavimab (branded as Evusheld), for severely immunocompromised New Zealanders
Don Matheson, Johanna Reidy and Rawiri Keenan say the health reforms have not presented a coherent vision for primary and community care. In this, the first of two articles, they fill in some gaps in a bid to spark policy discussion
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management